Bio Protocol vs Kaspa — how do they compare? Bio Protocol trades at Rp430.58 (market cap Rp974,32M, Rp147,16M 24h volume), while Kaspa trades at Rp446.79 (market cap Rp12,34T, Rp108,18M 24h volume). The key difference: Kaspa is far larger — about 12665.2× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 27,6B / 28,7B KAS (97%) for Kaspa. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Kaspa for 42 Days on average.
| BIO | KAS | |
|---|---|---|
Market Cap | Rp974,32M | Rp12,34T |
Volume (24h) | Rp147,16M | Rp108,18M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 27,6B / 28,7B KAS (97%) |
Typical Hold Time | 18 Days | 42 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Kaspa is trading at Rp448.25 with a market cap of Rp12.45T, showing a bearish technical signal across moving averages and oscillators. The price is near support at S1 (Rp447) with RSI_12 indicating potential oversold conditions. No major protocol updates or ecosystem developments were noted recently, and the circulating supply is high at 97% of the max supply of 28.7M KAS.
The overall outlook is cautious due to bearish technicals and lack of positive catalysts. Key opportunities include potential rebounds from oversold levels, but risks involve continued downward pressure, low liquidity, and crypto market volatility. Investors should monitor support levels and broader market sentiment.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Kaspa is a fast and scalable Layer-1 cryptocurrency built on a proof-of-work model, powered by the GHOSTDAG protocol. This protocol allows multiple blocks to coexist in a blockDAG structure. Kaspa can process 10 blocks per second, with plans to scale to 100 BPS, providing near-instant confirmation times. Designed for accessibility and decentralization, Kaspa runs smoothly on standard personal computers and supports future Layer-2 solutions for scalable and secure applications.
Read more on KAS →